Insights

Why 40% of GLP-1 Users Quit for Reasons Beyond Cost

GLP-1 Prices Just Plummeted

This morning, Novo Nordisk delivered a major disruption to the weight-loss and metabolic-health landscape: significantly lower prices for Wegovy and Ozempic. Most versions of the injections dropped from $499 to $349 a month, with new users able to purchase the…

Read MoreGLP-1 Prices Just Plummeted
The Great GLP-1 Reset Has Begun

The Great GLP-1 Reset Has Begun

President Trump’s new Medicare deal with Eli Lilly & Company and Novo Nordisk has reshaped the economics of weight loss. High-demand GLP-1 drugs such as Wegovy and Zepbound, once a $1,000-a-month treatment for a select few, will soon be available for about $245 under…

Read MoreThe Great GLP-1 Reset Has Begun